- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03046888
ROBOTIC PYELOLITHIOTOMY VERSUS PERCUTANEOUS NEPHROLITHOTOMY (PCNL).
February 13, 2020 updated by: Nessn Azawi, Zealand University Hospital
Prospectively randomized study in patients with renal pelvic stones who are candidate to standard PCNL procedure.
One to one, controlled clinical trial.
Patients will be randomly allocated into two groups, 20 patients in each group.
Group A will be scheduled to receive routine standard PCNL.
Group B will be scheduled to receive Robot assisted pyelolethotomy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Roskilde, Denmark, 4000
- Zealand University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age above 18 years.
- Renal stones ≥2 cm.
- Patients are candidate to PCNL.
- Patient with ECOG performance score of 2 and less.
- Able to give informed consent
- Able to discharges home at the same day.
Exclusion Criteria:
- Renal stones < 2cm and can managed by another technique.
- Known with psychological disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PCNL
Percutant nephrolithotomy is a standard procedure for stones treatment over 2 cm.The puncture will be performed with an 18-G nephrostomy needle.
The access thus gained guaranteed the transpapillary route of the percutaneous tract, a basic condition for the prevention of bleeding.
Subsequently, following withdrawal of the puncture needle and urine drainage, a flexible guidewire will be inserted and advanced to the upper calyx or ureter.
|
A 12-mm camera port is placed at the level of the umbilicus and lateral; this port is moved farther laterally in morbidly obese patients to allow for the instruments to reach the target organs.
Two 8-mm robotic trocars are placed under direct vision and a 12-mm assistant port is placed in the midline a 5-8 cm above the umbilicus.
For right-sided stones, an additional 5-mm port is placed in the midline just below the xiphoid process for liver retraction.
Placement of the trocars can be changed according to surgeon preference.
After reflecting the colon medially, the renal pelvis will be dissected and identified, a flexible cystoscope will be inserted via an assisted trocar and introduced into the renal pelvis through a minor incision.
The kidney stones will then be extracted with a basket and either removed via the port or placed in a specimen retrieval bag.
|
|
Experimental: Robot assisted pyelolithotomy
Robot assisted pyelolithotomy, is a new technique to remove stones of more than 2 cm.
A 12-mm camera port is placed at the level of the umbilicus and lateral.
Two 8-mm robotic trocars are placed under direct vision and a 12-mm assistant port is placed in the midline a 5-8 cm above the umbilicus.
After reflecting the colon medially, the renal pelvis will be dissected and identified, a flexible cystoscope will be inserted via an assisted trocar and introduced into the renal pelvis through a minor incision.
The kidney stones will then be extracted with a basket and either removed via the port or placed in a specimen retrieval bag.
|
A 12-mm camera port is placed at the level of the umbilicus and lateral; this port is moved farther laterally in morbidly obese patients to allow for the instruments to reach the target organs.
Two 8-mm robotic trocars are placed under direct vision and a 12-mm assistant port is placed in the midline a 5-8 cm above the umbilicus.
For right-sided stones, an additional 5-mm port is placed in the midline just below the xiphoid process for liver retraction.
Placement of the trocars can be changed according to surgeon preference.
After reflecting the colon medially, the renal pelvis will be dissected and identified, a flexible cystoscope will be inserted via an assisted trocar and introduced into the renal pelvis through a minor incision.
The kidney stones will then be extracted with a basket and either removed via the port or placed in a specimen retrieval bag.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative hospital stay
Time Frame: 30 days
|
the length of hospital stay efter each procedure
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Stones free rate
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Actual)
February 13, 2020
Study Completion (Actual)
February 13, 2020
Study Registration Dates
First Submitted
February 5, 2017
First Submitted That Met QC Criteria
February 5, 2017
First Posted (Estimate)
February 8, 2017
Study Record Updates
Last Update Posted (Actual)
February 17, 2020
Last Update Submitted That Met QC Criteria
February 13, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJ-598
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Stone
-
Ankara City Hospital BilkentCompletedRenal Stone | Ureter Stone | Kidney; Complications | Renal OxygenationTurkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
Ain Shams UniversityCompletedPercutaneous Nephrolithotomy (PCNL) | Renal Stone DiseaseEgypt
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Wisconsin, MadisonCompletedSurgery | Stone Ureter | Stone;RenalUnited States
-
Mansoura UniversityRecruitingUrinary Stones | Renal StoneEgypt
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Shiraz University of Medical SciencesCompletedRenal Pelvis Stone >3cmIran, Islamic Republic of
-
University of MichiganColoplast A/SCompletedRenal Stone | Ureteral StoneUnited States
-
National Cheng-Kung University HospitalCompleted
Clinical Trials on Robot assisted pyelolithotomy
-
Institut Paoli-CalmettesNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
RenJi HospitalUnknown
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Active, not recruiting
-
Universita di VeronaCompletedMultiple Sclerosis | RehabilitationItaly
-
University of PisaCompleted
-
National University Hospital, SingaporeNational University, Singapore; Agency for Science, Technology and ResearchCompleted
-
Yingxue HaoUnknown
-
UMC UtrechtCompletedEsophageal Cancer | Esophageal CarcinomaNetherlands
-
Chang Gung Memorial HospitalCompleted